Trial intelligence / Profile preview

Strengthening bowel-cleansing with Macrogol 3350 in patients with prior inadequate colonoscopy preparation

2019-001277-93Phase 4Active

Sponsor: "PrÃncipe de Asturias" University Hospital
Start: Jul 2019
Modality: Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems
Countries: 1

Overview

Phase 4, single-arm trial of polyethylene glycol in colorectal cancer (CRC) and colonic polyp, sponsored by "PrÃncipe de Asturias" University Hospital. Primary endpoint: Quality of colonoscopy bowel cleansing (Boston Bowel Preparation Scale by sections). Started Jul 2019; status: active.

Drugs

polyethylene glycol

Conditions

colorectal cancer (CRC)colonic polyp

Beyond the preview

Go deeper on 2019-001277-93.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2019-001277-93.